Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARBOPLATIN Cause Psychomotor hyperactivity? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Psychomotor hyperactivity have been filed in association with CARBOPLATIN (Carboplatin). This represents 0.0% of all adverse event reports for CARBOPLATIN.

13
Reports of Psychomotor hyperactivity with CARBOPLATIN
0.0%
of all CARBOPLATIN reports
0
Deaths
5
Hospitalizations

How Dangerous Is Psychomotor hyperactivity From CARBOPLATIN?

Of the 13 reports, 5 (38.5%) required hospitalization, and 1 (7.7%) were considered life-threatening.

Is Psychomotor hyperactivity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CARBOPLATIN. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does CARBOPLATIN Cause?

Off label use (6,100) Neutropenia (5,314) Anaemia (5,312) Febrile neutropenia (4,888) Nausea (4,588) Disease progression (4,538) Thrombocytopenia (4,483) Malignant neoplasm progression (4,177) Diarrhoea (4,154) Dyspnoea (3,494)

What Other Drugs Cause Psychomotor hyperactivity?

METHYLPHENIDATE (617) QUETIAPINE (412) ARIPIPRAZOLE (389) OLANZAPINE (366) SERTRALINE (288) MONTELUKAST (282) RISPERIDONE (277) LEVETIRACETAM (247) VENLAFAXINE (214) LEVOTHYROXINE (211)

Which CARBOPLATIN Alternatives Have Lower Psychomotor hyperactivity Risk?

CARBOPLATIN vs CARBOPROST TROMETHAMINE CARBOPLATIN vs CARBOXYMETHYLCELLULOSE CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN\POLYSORBATE 80 CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\HYPROMELLOSES

Related Pages

CARBOPLATIN Full Profile All Psychomotor hyperactivity Reports All Drugs Causing Psychomotor hyperactivity CARBOPLATIN Demographics